FDA Investigator: Emily B. Camire

- Emily B. Camire first started conducting FDA inspections in 2019, with the last inspection in 2024. Over that time, Emily B. Camire has conducted 59 inspections at 49 companies across 57 sites.

Get Emily Camire's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Chara Biologics, Inc., Chatsworth | 2024

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 University of California Irvine Medical Center Campus Donor Center, Irvine | 2024

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 Utah Lions Eye Bank, Salt Lake City | 2024

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 Donor Services Laboratory, Inc. Las Vegas, Las Vegas | 2024

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 Frontier Biologics LLC, Waco | 2024

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 BLS Labs, LLC, Scottsdale | 2024

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 CellSure, L3C, Salt Lake City | 2023

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 Utah Valley Hospital, Provo | 2023

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 GEV Co Ltd, Chungcheongbuk-Do | 2023

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 Eone Laboratories, Yeonsu | 2023

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 Hans Biomed Corporation, Yusung | 2023

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 MD Tox Laboratory, Irvine | 2023

Out-of-stock
Emily B. Camire
Biologics Form 483

FDA 483 American National Red Cross (The), Lewis and Clark Region, Murray | 2023

Out-of-stock
Emily B. Camire
Biologics Form 483